NICE has announced the launch of the National HealthTech Access Programme, a new approach designed to give people across England and Wales faster, fairer access to innovative health technologies.
The programme was unveiled in a NICE news update on 9 February 2026 and forms part of the wider ambition to improve how new devices, diagnostics and digital products are evaluated and adopted across the health service. NICE says the approach will expand its technology appraisal programme so that high-impact technologies can be assessed in a way more closely aligned with the process already used for medicines.
First topics include cancer detection and AI tools
According to NICE, the first two topics to enter the new programme are capsule sponge tests for detecting oesophageal cancer and AI tools for identifying prostate and breast cancer. The organisation says these technologies could improve early diagnosis for thousands of patients each year while also helping to free up NHS capacity.
The update says the initiative is being delivered in collaboration with the Department of Health and Social Care, NHS England, the MHRA and the Office for Life Sciences. NICE describes it as a strategic open innovation approach intended to strengthen access to HealthTech and support the NHS 10 Year Health Plan.
A broader shift in how HealthTech reaches patients
The new programme builds on recent changes that put health technologies on a more equal footing with medicines in national assessment and reimbursement decisions. NICE says the aim is to create a clearer route for technologies that can deliver meaningful benefits to patients and the NHS, while improving consistency of access across the country.
That matters because adoption of new technology has often been uneven across different parts of the NHS. NICE says the programme is designed to address that challenge by supporting faster decisions and clearer implementation pathways for technologies that meet its standards.
For patients, the practical effect could be quicker access to innovations that support earlier diagnosis and more efficient care. For clinicians and health systems, the change may also help reduce variation, simplify adoption and improve the use of limited workforce and diagnostic resources.
The move comes as NHS leaders continue to face pressure to modernise services while managing long waiting lists and rising demand. NICE’s latest update suggests HealthTech will play an increasingly prominent role in that effort, particularly where digital tools and diagnostic innovations can help the NHS deliver care more consistently and at greater scale.
As the first topics move through the new pathway, attention will now turn to whether the programme can translate policy ambition into faster real-world access for patients.
Sursa foto: Imagine generată AI
